Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Non Operating Income (2021 - 2026)

HeartSciences filings provide 6 years of Non Operating Income readings, the most recent being -$56268.0 for Q1 2026.

  • On a quarterly basis, Non Operating Income rose 65.86% to -$56268.0 in Q1 2026 year-over-year; TTM through Jan 2026 was -$688440.0, a 235.66% decrease, with the full-year FY2025 number at -$412658.0, down 37.81% from a year prior.
  • Non Operating Income hit -$56268.0 in Q1 2026 for HeartSciences, up from -$277366.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $33626.0 in Q2 2024 to a low of -$277366.0 in Q4 2025.
  • Median Non Operating Income over the past 5 years was -$97885.0 (2024), compared with a mean of -$98910.2.
  • Biggest five-year swings in Non Operating Income: soared 199.77% in 2024 and later crashed 854.34% in 2025.
  • HeartSciences' Non Operating Income stood at -$31606.0 in 2022, then tumbled by 464.56% to -$178435.0 in 2023, then soared by 45.14% to -$97885.0 in 2024, then crashed by 183.36% to -$277366.0 in 2025, then surged by 79.71% to -$56268.0 in 2026.
  • The last three reported values for Non Operating Income were -$56268.0 (Q1 2026), -$277366.0 (Q4 2025), and -$180875.0 (Q3 2025) per Business Quant data.